Dano Health Group is your authoritative one-stop pharmaceutical supplier. Get in touch with us today to deliver your anti-cancer and oncology requirement drugs at a competitive price.
We are honored to provide you with Dano product records (more than 17,000 items) available in the Turkish market only for your email address. Moreover, we will send you Dano Profile, and Best-selling list for your reference to your email address.
Our company is honored to supply all COVID19 PPEs in high quality with full supportive documents and essential certificates and standards of the European Union and the USA at fair prices.
Dano has established its offices at strategic pharmaceutical supply countries in the world including Turkey, Italy, and India to provide its clients best services.
Align with Dano Health group mission and vision our business philosophy as a pharmaceutical wholesaler and Supplier is making more turnover with less margin. A strong and long-term relationship with our customers is vital to our business. Together, we contribute to making an efficient pharmaceutical supply chain that lowers health costs for both the public and the private sectors.
We are completely ready to provide our clients with their required documents related to their shipments such as certificate of origin (COO), certificate of analysis (COA), and other necessary certificates requested by clients.
Dano standard is running procedures with a strict policy to guaranty a constantly high level of delivery system within the necessary procurements for normal or controlled temperature cargos. This accuracy powers us to deliver the required products completely based on the MSDS (Material Safety Data Sheet).
Sitagliptin previously identified as MK-0431 and marketed as the phosphate salt under the trade name Januvia is an oral Type 2 diabetes medication manufactured by Merck & Co. This new oral hypoglycemic (anti-diabetic) drug is the top-selling brand in its class. In 2007, an oral combination of sitagliptin and metformin was marketed in the US as Janumet.
Lenalidomide with the trade name Revlimid is imitative of thalidomide which was introduced in 2004 and developed by modification of the structural backbone of thalidomide. It was intended as a treatment for multiple myeloma at first while thalidomide is an accepted therapeutic treatment for it.
GRAN® (Filgrastim) is a human Colony-Stimulating Factor (G-CSF) that is produced by genetic recombination technology. Pegfilgrastim is a Pegylated form of GCSF (Analog Filgrastim ) manufactured by Amgen (U.S.) and Kyowa Hakko Kirin (Japan).
From now till spread of Health
Dano is an international medical device producer and brand-owner that is honored to supply COVID-19 protective products all around the world. Dano group will stand by you and we will fight COVID-19 together untill the complete overcome to this virus.